Educational guide
Adipotide Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!
How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C111H206N36O28S2 Molecular Formula 2611.41 g/mol Molecular Weight ~24 hours Half-Life High (subcutaneous injection) B
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
How much do I take?
Is this right for me?
How do I use it?
Is it safe?
How do I know it's working?
Compound Profile
Scientific & Efficacy Data
C111H206N36O28S2
Molecular Formula
2611.41 g/mol
Molecular Weight
~24 hours
Half-Life
High (subcutaneous injection)
Bioavailability
859216-15-2
CAS #
163360068
PubChem ID ↗
Developed By · 2004
Wadih Arap and Renata Pasqualini
University of Texas MD Anderson Cancer Center
Primary Benefits
One of the most potent fat-reducing compounds studied in primates, working through direct destruction of fat tissue blood supply rather than metabolic pathways.
Significant improvements in insulin sensitivity and metabolic markers observed in all primate studies, with effects persisting beyond the treatment period.
Exceptionally fast-acting for a fat-loss compound, with measurable results appearing within 1-2 weeks and dramatic changes by week 4 of treatment.
Amino Acid Sequence
Dosing
How muchdo I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Starting Dose
0.10 mg/kg
Frequency
Once daily
Duration
About 2 weeks before stepping up
Adipotide is research-only and has never been approved for people. These numbers come from a dose-finding study in obese monkeys, where the dose was raised step by step every 2 weeks. The first human Phase 1 study started even lower, at 0.03 mg/kg daily. [2]
Standard Dose
0.25 mg/kg
About 2 weeks at this step
Middle step in the monkey dose-finding study. Not an approved human dose. [2]
Advanced Dose
0.43 mg/kg
Up to ~3-4 weeks at this level (studies ran 28 days at the top dose)
This was the best-working ("optimal") dose in obese monkeys, leading to about 10.6% body-weight loss over 28 days. It is from animal research and is not an approved or established human dose. [2]
Timing
Best time to take
Morning, at a consistent time each day
With food?
Can be administered with or without food. Ensure adequate hydration throughout the day.
If stacking
If using BPC-157 for potential renal support, administer at a different time of day. Avoid combining with other nephrotoxic substances.
Adjusting Your Dose
Increase if
+Tolerating current dose well with stable kidney markers
+Minimal side effects after 1-2 weeks
+Fat loss progress has plateaued at current dose
+Serum creatinine remains within normal range
Decrease if
-Serum creatinine rises above normal range
-Significant proteinuria or glucosuria develops
-Signs of dehydration despite adequate fluid intake
-Any concerning changes in urination patterns
Signs of right dose
✓Steady fat loss of 2-3% body weight per week
✓Stable kidney function markers
✓Improved insulin sensitivity on bloodwork
✓No significant side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Suitability
Is thisright for me?
Best For
Targeted White Fat Reduction
Adipotide specifically seeks out and destroys the blood vessels feeding white adipose tissue. Unlike diet or exercise that shrink fat cells, this peptide actually eliminates fat tissue by cutting off its blood supply - a completely unique mechanism.
Stubborn Fat Deposits
Because it targets the vasculature of fat tissue directly, Adipotide may be particularly effective for stubborn fat deposits that resist traditional methods. The peptide homes in on prohibitin receptors found specifically on blood vessels supplying fat tissue.
Improving Insulin Resistance
Primate studies showed remarkable improvements in insulin sensitivity - treated monkeys used about 50% less insulin after treatment. This makes it interesting for research into obesity-related metabolic dysfunction.
Research Applications
As a pioneering vascular-targeting peptide, Adipotide represents a new class of potential therapeutics. Its unique mechanism of targeting specific tissue vasculature has implications beyond obesity research.
Consider Alternatives If
Goal: Fat loss with established safety profile
Consider: Semaglutide, Tirzepatide, AOD-9604
Goal: Improving insulin sensitivity
Consider: Semaglutide, Tesamorelin, Metformin
Goal: Research into fat reduction mechanisms
Consider: AOD-9604, MOTS-c, 5-Amino-1MQ
Who Should Avoid
Do not use if
×You have any form of kidney disease or impaired renal function
×You are pregnant, trying to conceive, or breastfeeding
×You have a history of severe allergic reactions to peptides
×You are taking other nephrotoxic medications
×You have chronic dehydration or conditions affecting fluid balance
×You cannot commit to regular kidney function monitoring
Use with caution if
!You are taking NSAIDs or other medications affecting kidney function
!You have a history of kidney stones
!You have diabetes (blood sugar monitoring needed)
!You are over 65 years of age
!You have cardiovascular conditions
!You are taking diuretics or blood pressure medications
Not Sure?
Compare Adipotide with similar peptides to find the best fit for your goals.
Administration
How do Iuse it?
Reconstitution
What you need
•Bacteriostatic water (BAC water)
•Insulin syringe (29-31 gauge)
•Alcohol swabs
•Sterile vial of Adipotide powder
•Calculator for dose calculation based on body weight
Example
10mg vial + 2mL BAC water = 5mg/mL concentration. For an 80kg person at 0.25 mg/kg dose: 80 x 0.25 = 20mg needed. At 5mg/mL, draw 4mL total (split into multiple injections if needed).
Calculate your dose in mg by multiplying your body weight in kg by the mg/kg dose. Then divide by your concentration to get the volume to inject.
Injection
Route
Subcutaneous injection once daily
Best sites
•Abdomen (2 inches from navel)
•Front of thigh (middle third)
•Upper arm (outer area)
Technique
1.Calculate your dose based on body weight and verify the math
2.Clean injection site thoroughly with alcohol swab and let dry
3.Pinch skin to create a fold at the injection site
4.Insert needle at 45-90 degree angle depending on body composition
5.Inject slowly and steadily
6.Remove needle and apply light pressure - do not rub
Storage
Before reconstitution
Store lyophilized powder at -20°C for long-term storage (up to 2 years) or 2-8°C for short-term storage (up to 3 months). Keep in original container protected from light. Do not expose to repeated freeze-thaw cycles.
After reconstitution
Refrigerate immediately at 2-8°C. Store upright to prevent contamination of the stopper. Use within 14 days of reconstitution. Never freeze reconstituted solution as this will destroy the peptide.
Signs of degradation
Cloudy or discolored solution (should be clear)
Visible particles or floaters in solution
Solution that fails to fully dissolve
Any unusual odor
Sample Daily Schedule
Morning (7:00-9:00 AM)
Calculated based on body weight and current tier injection
Site: Rotate between abdomen, thigh, and arm
Take at the same time each day. Drink at least 8-10 glasses of water daily. Monitor urine color - should be light yellow.
Safety
Is itsafe?
Safety Profile
Adipotide has been extensively studied in mice, rats, and three species of primates with consistent results. The primary safety concern is dose-dependent kidney effects, which were reversible upon stopping treatment in all studies. No cardiovascular, neurological, or hepatic adverse events were observed. The compound shows remarkable selectivity - lean animals given the same doses experienced no weight loss, suggesting it specifically targets excess fat tissue.
Safety data comes from well-designed primate studies published in peer-reviewed journals including Science Translational Medicine. However, there are no human clinical trials, so the full safety profile in humans remains unknown. The reversibility of kidney effects in primates is encouraging but requires validation in human studies.
Common Side Effects
Experienced by some users
Elevated Serum Creatinine
The most consistently observed effect in primate studies, indicating the kidneys are processing the compound.
Management: Monitor with regular blood tests. Usually normalizes within 4 weeks of stopping treatment. Stay well-hydrated.
Proteinuria
Mild to moderate protein appearing in urine, reflecting kidney filtration changes.
Management: Monitor with urinalysis. Reduce dose if marked. Ensure adequate hydration.
Glucosuria
Glucose appearing in urine even with normal blood sugar, due to effects on kidney tubules.
Management: Monitor blood glucose to ensure it remains normal. Not typically concerning if blood sugar is stable.
Reduced Appetite
Decreased food intake observed in all treated animals - appears to be genuine appetite reduction rather than nausea.
Management: Ensure adequate protein intake despite reduced appetite. This effect contributes to weight loss.
Less Common
•Mild Dehydration
•Injection Site Reactions
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
×Serum creatinine rises significantly above your baseline
×Marked proteinuria that persists or worsens
×Signs of kidney problems (pain in lower back, changes in urination)
×Severe or persistent dehydration despite adequate fluid intake
×Any allergic reaction (rash, swelling, difficulty breathing)
×Completion of the recommended 4-week treatment cycle
Adipotide is a research compound without FDA approval. Use only under medical supervision with regular kidney function monitoring. Stop immediately and consult a healthcare provider if you experience any concerning symptoms.
Interactions
With other peptides
✓May provide protective effects for kidneys - consider using for support
✓No known interactions, but avoid adding kidney stress
!Both target fat loss through different mechanisms - use caution with combination
!Different mechanisms but overlapping goals - not recommended to combine
With medications
!NSAIDs (Ibuprofen, etc.) - Can compound kidney stress - avoid during Adipotide use
!ACE Inhibitors - May affect kidney function - monitor closely if combining
!Diuretics - Increases dehydration risk significantly - avoid combination
✓Metformin - Generally safe but monitor kidney function more frequently
With supplements
✓Electrolytes - Highly recommended to maintain proper hydration and mineral balance
✓Protein supplements - Recommended to preserve muscle mass during rapid fat loss
✓Creatine - May confound creatinine monitoring - consider stopping during treatment
✓High-dose Vitamin C - Very high doses may affect kidney stone risk - use moderate amounts
Effectiveness
Does itwork?
Evidence Level
Strong preclinical
What to Expect
Week 1
What you might notice
•Possible slight decrease in appetite
•No dramatic weight changes yet
•Injection site may have minor redness
•Increased thirst as body adjusts
What's normal
•Mild elevation in creatinine on blood tests
•Slight changes in urination patterns
•Body weight relatively stable
What's next
→Continue monitoring kidney function
→Maintain excellent hydration
→Prepare to assess tolerance for dose increase
Week 2-3
•Noticeable reduction in appetite
•Beginning of measurable weight loss (3-7%)
•Clothes may start fitting differently
•Possible increase in energy as fat decreases
•Steady weight loss of 2-3% per week
•Continued mild kidney marker changes
•Reduced food intake without feeling ill
→Continue at current dose if tolerating well
→Mid-cycle kidney function check recommended
→Ensure protein intake remains adequate
Week 4
•Significant fat loss visible (7-15% body weight reduction)
•Waist circumference noticeably reduced
•Improved metabolic markers on bloodwork
•Better insulin sensitivity
•Total weight loss of 10-15% from baseline
•Peak kidney marker changes
•Appetite significantly reduced from baseline
→Complete the treatment cycle
→Schedule post-treatment kidney function tests
→Plan recovery period of at least 4 weeks
Recovery (Week 5-8)
•Kidney markers returning to normal
•Appetite gradually returning
•Weight may stabilize at new lower level
•Improved metabolic health may persist
•Creatinine normalizing within 2-4 weeks
•Some appetite recovery
•Maintained fat loss if diet is controlled
→Confirm kidney function fully normalized
→Focus on maintaining results through diet
→Assess if another cycle is appropriate after full recovery
Signs It's Working
Fat Loss Progress
✓Steady decrease in body weight (2-3% per week at optimal dose)
✓Reduction in waist and abdominal circumference
✓Visible reduction in subcutaneous fat
✓Clothes fitting looser, especially around midsection
✓DEXA or body composition scans showing fat mass decrease
Metabolic Improvements
✓Lower fasting insulin levels on bloodwork
✓Improved insulin sensitivity markers
✓Better fasting glucose readings
✓Reduced inflammatory markers
✓Improved lipid profile
Appetite and Behavior
✓Naturally reduced appetite without nausea
✓Feeling satisfied with smaller meals
✓Reduced cravings for high-calorie foods
✓More stable energy throughout the day
Not Seeing Results?
Common reasons
•Dose too low - the therapeutic dose of 0.43 mg/kg was needed for optimal results in primates
•Not enough time - significant results require 3-4 weeks of consistent use
•Poor quality peptide - ensure sourcing from reputable research suppliers
•Inadequate hydration - dehydration can stress kidneys and reduce effectiveness
•Inconsistent dosing - daily administration is important for maintaining tissue levels
•Already lean - the peptide specifically targets excess fat and shows less effect in lean subjects
Key Research
[1]"Reversal of obesity by targeted ablation of adipose tissue"
Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W, 2004
Finding: This foundational study discovered that the CKGGRAKDC peptide homes to white fat blood vessels by binding prohibitin. When linked to a cell-death-inducing sequence, it caused targeted destruction of fat tissue and rapid obesity reversal in mice without detectable side effects.
[2]"A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys"
Barnhart KF, Christianson DR, Hanley PW, et al., 2011
Finding: Obese rhesus monkeys lost an average of 11% body weight in just 4 weeks of treatment. MRI confirmed 17-27% reduction in white adipose tissue. Treated monkeys showed 50% improvement in insulin sensitivity. Kidney effects were predictable and fully reversible.
[3]"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma"
Kolonin MG, Pasqualini R, Arap W, 2011
Finding: This study validated the peptide screening platform used to discover Adipotide and demonstrated how targeting specific vascular markers can be used therapeutically. The approach has implications beyond obesity for targeted drug delivery.
[4]"Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight"
Kim DH, Woods SC, Seeley RJ, 2010
Finding: Confirmed that the proapoptotic peptide targeting fat vasculature reduces food intake in addition to directly destroying fat tissue. This dual mechanism may contribute to its effectiveness for weight loss.
Organ Targets
Powered by Human Organ Atlas
Organs and body systems affected by Adipotide, mapped to the Human Organ Atlas — an open-access 3D portal featuring 56 organs imaged at near-cellular resolution.
Kidneys
Urinary System
Renal monitoring required — affects kidney proximal tubule cells as an off-target effect
The Science
Stacking & Combinations
Frequently Asked Questions